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Additional Indexing Words: Long-term chemoprophylaxis Rheumatic heart disease Antistreptolysin O titer HE diagnostic criteria originally proposed by Jones in 19441) proved useful for guidance in the diagnosis of rheumatic fever (RF). The rapidly expanded knowledge on RF and rheumatic heart disease (RHD) called for, however, a modification of it in 1955.2) A revision of the modified Jones criteria was again made in 1965 emphasizing the importance of establishing antecedent streptococcal infection, by which overdiagnosis might be avoided thus preventing creation of unnecessary anxiety and administration of prolonged chemoprophylaxis.3), 4) The revised Jones criteria were designed to establish the diagnosis in patients during the acute stage of RF.3) Although the exception rules3) to the revised Jones criteria were made to cover the diagnosis in cases of low grade carditis or Sydenham's chorea, certain difficulties may be anticipated when these criteria are to be applied in patients who come late to medical attention or in those whose clinical and laboratory manifestations are atypical. During 1967-1971, we have encountered 32 cases of rheumatic fever, whose manifestations met only the modified but not the revised criteria. We labeled these cases as probable RF and enrolled them into a prospective study. We treated and followed them on the same schedule as for those with definite RF, and their outcomes were studied. The present communication is to report the outcomes of these 32 cases. The diagnoses in these cases are checked in the light of their outcomes. The risk factors causing underdiagnosis are discussed.
MATERIAL AND METHODS
One hundred and thirty consecutive cases who were very suspicious of RF and high ASO titers. Of the 3 cases without definite carditis, 2 had polyarthritis, two minor manifestations, and low ASO titers; 1 had polyarthritis, one minor, and high ASO titers. Absence of the increase of ASO titers (in 29 cases), and shortage of one minor manifestation (in 3 cases) were the reasons leading to exclusion by the revised Jones criteria. All cases were treated with penicillin for eradication of the group A streptococcus which might still harbor in their throats. For those with definite carditis, large dose short-term steroid treatment using prednisolone for 10 to 14 days, followed by aspirin, 0.1Gm/Kg daily for a period of a few weeks to several months, was prescribed. For those with no carditis, aspirin only was given for symptomatic relief. They were rigidly advised to stay in the long-term penicillin prophylaxis for streptococcal infection. They were followed by one of the authors for 1 month to 6 years with an average of 3.7 years at the Cardiac Clinic.
RESULTS
According to the length of follow-up and the compliance to chemoprophylaxis all the 32 cases were divided into groups A, B, and C as listed in Table V . Twenty cases who stayed well in the prophylactic program for 1 to 6 years (average 4.4 years) were included into group A. Six cases, who were non-compliant to prophylactic medication, but kept coming irregularly to the clinic for 1 to 6 years (average, 4.5 years) were put in group B. Another 6 cases who dropped out soon after discharge from the hospital were in group C.
The outcomes in each group (A, B, and C) were quite different as listed in Table VI. Group A: In 3 cases the heart size became normal and the murmur disappeared in 4 years and 7 months, 1 year and 5 months, and 3 years and 6 months respectively.
In 5 cases the cardiac size became normal or nearly normal with persistence of the murmurs.
In 8 the murmur persisted and the cardiac size became significantly smaller. Two cases responded initially to treatment but required replacement of the mitral valve 5 and 6 years later. Two cases (cases 2 and 4) who had polyarthritis with no definite carditis remained free of heart disease; The faint systolic murmur heard in case 2 disappeared soon after treatment.
A typical RF recurrence manifested as polyarthritis occurred in case 4. Group B: The outcomes in group B patients who were non-compliers to chemoprophylaxis were poorer. The cardiac size remained unchanged in one, and became more enlarged in another case. One case required replacement of the mitral valve. Two died of heart failure in 2 and 4 years respectively. The case without carditis remained free of heart disease.
Group C: Four responded to treatment initially and the heart size decreased but then lost to follow-up.
One improved following treatment, and the murmur changed and turned out to be a case of pure mitral stenosis 3 months later. One died of heart failure in 2 months. Autopsy revealed changes of rheumatic carditis. Eight typical recurrences of RF were noted in 8 cases. Diagnosis of RF was thus justified or confirmed in 27 cases. The diagnosis in the rest of 5 cases failed, however, to be checked in the light of their outcomes, and remained neither confirmed nor negated.
DISCUSSION
The revision of the modified Jones criteria made in 1965 emphasized the importance of establishing antecedent streptococcal infections. The chances of overdiagnosis may thus be avoided, or reduced to a minimum especially in cases of polyarthritis.3),9) In the practical application of these criteria, the problem of underdiagnosis has, however, frequently occurred.5),6),9) So far the clinical diagnosis of RF remains to be made on the basis of empirical data, validation of the diagnosis is, often, more than difficult. Justification or confirmation of the diagnosis can, however, be made by observing the long-term follow-up results of the patients under study.
Valvular heart diseases occurring in childhood are, in the majority, of rheumatic etiology.10) The valve disease may also occur, though rarely, in cardiomyopathy, infective endocarditis, rheumatoid disease, mucopolysaccharidosis, intracardiac myxoma, and various congenital cardiac malformations. With exception of certain types of cardiomyopathy, non-rheumatic valvular heart diseases almost never regress or heal unless specific medical or surgical treatment has been carried out. Acute rheumatic carditis may heal and leave no clinical evidence of heart disease. In a study of 653 patients with RHD, conducted before the era of prophylaxis, Bland and Jones18) found that at the end of 10 years the physical signs of heart disease had disappeared in 76 (11%) instances, and at the end of 20 years in 108 (16%). Regression of the heart disease occurs more commonly following administration of the long-term chemoprophylaxis. In the joint study of Great Britain and the United States the cardiac murmur was found to have disappeared at 5 years in 30 to 74% of patients who had mitral valve involvement with or without congestive heart failure.19) Tompkins et al20) reported that of the 79 patients who had acute mitral regurgitation and maintained good prophylaxis, 70% lost their murmurs from 4 days to 8.5 years after it was first heard; of the 15 patients with acute aortic regurgitation the murmur disappeared in 27%. The diagnosis of RF may, therefore, be considered as justified if a patient responded clinically to anti-rheumatic treatment followed by normalization of the enlarged heart and disappearance of the murmur. The diagnosis may also be deemed as justified if the symptoms improve and the enlarged heart becomes smaller. It is recognized that most of the acquired pure mitral stenosis is of rheumatic etiology.10) The diagnosis of RF becomes justified if the cardiac murmur changed during the course of treatment and a pure mitral stenosis ensued.
It has been increasingly known that rheumatic carditis may not be the only cause of chronic rheumatic type valve pathology.10),12),13) The chance of being rheumatic becomes the greatest, if there had been a documented history of RF, or a new RF recurrence develops during the follow-up period. The initial diagnosis of RF was considered as justified in 8 cases of our series in this context.
In 27 cases of the present series the diagnosis of RF is thus justified. This means that under-diagnosis would have resulted at least in these 27 cases, if only the revised criteria were used. The causes leading to under-diagnosis in these cases are as follows: 1) coming late to seek after medical attention; 2) no response in ASO titers; 3) limited studies for the supportive evidence of preceding streptococcal infections, and 4) drug induced modification of the major and/or minor manifestations.
Feinstein et al7) found that the duration of acute inflammatory activity of RF varied from an average of 89 days to 124 days. The duration was noted to be longer in patients who had carditis, and in those who had been treated with steroids. The rise of the anti-streptococcal antibody titers usually becomes detectable in the second week following streptococcal infection and reaches a maximum level at 4 to 6 weeks.11) It remains high for a variable period of time and then starts declining gradually to a non-significant level in about 2 months. It is therefore quite possible that the evidences of preceding streptococcal infection may have disappeared long before the rheumatic activity subsides. The interval between the onset of RF and the time of our observation was usually long in the present series of patients. Of the 27 cases underdiagnosed, 16 were first brought under observation 2 months or longer since the onset of RF.
Stollerman et al14) and Wood et al11) reported that in about 10 to 20% of patients with RF no definite elevation in ASO titers was demonstrated even early in the course of the disease. In 8 cases of our series the ASO titer failed to rise despite that they came under observation within 2 months following their onsets of the disease.
In 24 of the 27 cases underdiagnosed by the revised Jones criteria, no evidences of preceding streptococcal infection were obtained. Had more specimens for the throat culture, or tests for other streptococcal antibodies such as anti-hyaluronidase and anti-streptokinase been undertaken, underdiagnosis in these cases might have been prevented.
The drugs prescribed, and the dosage and duration administered in each case by the general practitioners or at the local hospitals were not specifically studied. Antibiotics, steroids, and antipyretics including aspirin were, however, the regimens commonly used. Penicillin therapy as reported by Kilbourne et al15) may suppress the ASO responses if given early in the course of the streptococcal infection. Steroids, as noted by Hahn et al16), may cause a delay in the development of streptococcal antibodies. The acute phase reactions, or the known indices of rheumatic activity such as elevated erythrocyte sedimentation rate, appearance of C-reactive protein and increased white blood cell counts, may be seriously influenced by the steroid and/or aspirin therapy.11) Polyarthritis and fever usually respond well or dramatically to the medication. Of the 32 cases studied, 25 had received some medications for one or more weeks prior to coming under observation. Application of the revised Jones criteria to these patients becomes, therefore, not logical and requires special considerations. It is suggested that the above mentioned risk factors associated with underdiagnosis should be taken into consideration in the practical application of the revised Jones criteria.
The outcomes of RF patients are known to vary with many factors, such as the length of illness prior to admission, the severity of carditis at the start of treatment, the drugs used, the compliance with the long-term chemoprophylaxis, and the frequency of RF recurrence.4),5),7),19)-22) Among the various prognostic factors, chemoprophylaxis plays the key role, exerting the most certain and beneficial effect.20)-22) The utterly different outcomes in each compliance group of the present study attest to the importance of long-term medication for prevention of RF recurrences. The present study implicates that those who are very suspicious of RF on the modified Jones criteria but fail tomeet the revised criteria, especially those with established valvular heart disease, should not be denied the diagnosis of RF, but should be labeled as probable RF, and be treated, followed, and placed on long-term medication prophylaxis until proved otherwise. Recurrence of RF may thus be prevented, and regression of the cardiac lesions may run its way.
